Search Results - "Gold, Michael R."

Left bundle branch pacing for symptomatic bradycardia: Implant success rate, safety, and pacing characteristics by Li, Yuqiu, Chen, Keping, Dai, Yan, Li, Chao, Sun, Qi, Chen, Ruohan, Gold, Michael R., Zhang, Shu

“…In patients with or without left bundle branch block, left bundle branch pacing (LBBP) can produce near normalization of QRS duration (QRSd). This has recently…”
Get full text

Antigen Receptor Function in the Context of the Nanoscale Organization of the B Cell Membrane by Gold, Michael R, Reth, Michael G

“…The B cell antigen receptor (BCR) plays a central role in the self nonself selection of B lymphocytes and in their activation by cognate antigen during the…”
Get full text

Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT by Van Gelder, Isabelle C, Healey, Jeff S, Crijns, Harry J G M, Wang, Jia, Hohnloser, Stefan H, Gold, Michael R, Capucci, Alessandro, Lau, Chu-Pak, Morillo, Carlos A, Hobbelt, Anne H, Rienstra, Michiel, Connolly, Stuart J

“…ASSERT demonstrated that subclinical atrial fibrillation (SCAF) is common in pacemaker patients without prior AF and is associated with increased risk of…”
Get full text

Can We Treat an Older Patient With a New Trick? by Karimianpour, Ahmadreza, Gold, Michael R.

“…[Display omitted]…”
Get full text

Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator by Weiss, Raul, Knight, Bradley P., Gold, Michael R., Leon, Angel R., Herre, John M., Hood, Margaret, Rashtian, Mayer, Kremers, Mark, Crozier, Ian, Lee, Kerry L., Smith, Warren, Burke, Martin C.

“…BACKGROUND—The most frequent complications associated with implantable cardioverter-defibrillators (ICDs) involve the transvenous leads. A subcutaneous…”
Get full text

Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events by Brambatti, Michela, Connolly, Stuart J, Gold, Michael R, Morillo, Carlos A, Capucci, Alessandro, Muto, Carmine, Lau, Chu P, Van Gelder, Isabelle C, Hohnloser, Stefan H, Carlson, Mark, Fain, Eric, Nakamya, Juliet, Mairesse, Georges H, Halytska, Marta, Deng, Wei Q, Israel, Carsten W, Healey, Jeff S

“…BACKGROUND—Among patients with implantable pacemakers and defibrillators, subclinical atrial fibrillation (SCAF) is associated with an increased risk of…”
Get full text

Safety and Efficacy of the Subcutaneous Implantable Defibrillator by Lewis, Geoffrey F., MD, Gold, Michael R., MD, PhD

“…Abstract Multiple randomized, multicenter trials have established the role of the implantable cardioverter-defibrillator (ICD) in the treatment and prevention…”
Get full text

Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial by Gold, Michael R., MD, PhD, Van Veldhuisen, Dirk J., MD, PhD, Hauptman, Paul J., MD, Borggrefe, Martin, MD, Kubo, Spencer H., MD, Lieberman, Randy A., MD, Milasinovic, Goran, MD, Berman, Brett J., MD, Djordjevic, Sanja, MD, Neelagaru, Suresh, MD, Schwartz, Peter J., MD, Starling, Randall C., MDs, MPH, Mann, Douglas L., MD

“…Abstract Background Heart Failure (HF) is increasing in prevalence and is a major cause of morbidity and mortality, despite advances in medical and device…”
Get full text

Subclinical Atrial Fibrillation and the Risk of Stroke by Healey, Jeff S, Connolly, Stuart J, Gold, Michael R, Israel, Carsten W, Van Gelder, Isabelle C, Capucci, Alessandro, Lau, C.P, Fain, Eric, Yang, Sean, Bailleul, Christophe, Morillo, Carlos A, Carlson, Mark, Themeles, Ellison, Kaufman, Elizabeth S, Hohnloser, Stefan H

“…A cohort of 2580 patients with pacemakers or defibrillators were monitored for 3 months to detect subclinical atrial tachyarrhythmias. Patients with…”
Get full text

Evaluation, Management, and Outcomes of Patients Poorly Responsive to Cardiac Resynchronization Device Therapy by Varma, Niraj, Boehmer, John, Bhargava, Kartikeya, Yoo, Dale, Leonelli, Fabio, Costanzo, Mariarosa, Saxena, Anil, Sun, Lixian, Gold, Michael R., Singh, Jagmeet, Gill, John, Auricchio, Angelo

“…“Nonresponse” to cardiac resynchronization therapy (CRT) is recognized, but definition(s) applied in practice, treatment(s), and their consequences are little…”
Get full text

The impact of chronotropic incompetence on atrioventricular conduction times in heart failure patients by Niu, Hongxia, Yu, Yinghong, Ravikumar, Vasanth, Gold, Michael R.

“…Background Intrinsic atrioventricular (AV) conduction is used to optimize AV intervals with cardiac resynchronization therapy (CRT) in most device algorithms…”
Get full text

Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial―Cardiac Resynchronization Therapy (MADIT-CRT) by ZAREBA, Wojciech, KLEIN, Helmut, GOLDBERGER, Jeffrey J, GOLDENBERG, Ilan, LICHSTEIN, Edgar, PITSCHNER, Heinz, RASHTIAN, Mayer, SOLOMON, Scott, VISKIN, Sami, WANG, Paul, MOSS, Arthur J, CYGANKIEWICZ, Iwona, HALL, W. Jackson, MCNITT, Scott, BROWN, Mary, CANNOM, David, DAUBERT, James P, ELDAR, Michael, GOLD, Michael R

“…This study aimed to determine whether QRS morphology identifies patients who benefit from cardiac resynchronization therapy with a defibrillator (CRT-D) and…”
Get full text

Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication by Boersma, Lucas V., MD, PhD, Barr, Craig S., MD, Burke, Martin C., DO, Leon, Angel R., MD, Theuns, Dominic A., PhD, Herre, John M., MD, Weiss, Raul, MD, FACS, FHRS, Kremers, Mark S., MD, FHRS, Neuzil, Petr, MD, PhD, Husby, Michael P., MS, FHRS, Carter, Nathan, MS, Stivland, Timothy M., BS, MBA, Gold, Michael R., MD, PhD

“…Background The subcutaneous implantable defibrillator (S-ICD) provides an alternative to the transvenous ICD for the prevention of sudden cardiac death, but…”
Get full text

Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms by Linde, Cecilia, MD, PhD, Abraham, William T., MD, FACC, Gold, Michael R., MD, PhD, St. John Sutton, Martin, MD, Ghio, Stefano, MD, Daubert, Claude, MD

“…Objectives We sought to determine the effects of cardiac resynchronization therapy (CRT) in New York Heart Association (NYHA) functional class II heart failure…”
Get full text

Control of the Hippo Pathway by Set7-Dependent Methylation of Yap by Oudhoff, Menno J., Freeman, Spencer A., Couzens, Amber L., Antignano, Frann, Kuznetsova, Ekaterina, Min, Paul H., Northrop, Jeffrey P., Lehnertz, Bernhard, Barsyte-Lovejoy, Dalia, Vedadi, Masoud, Arrowsmith, Cheryl H., Nishina, Hiroshi, Gold, Michael R., Rossi, Fabio M.V., Gingras, Anne-Claude, Zaph, Colby

“…Methylation of nonhistone proteins is emerging as a regulatory mechanism to control protein function. Set7 (Setd7) is a SET-domain-containing lysine…”
Get full text

Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study by Linde, Cecilia, Gold, Michael R, Abraham, William T, St John Sutton, Martin, Ghio, Stefano, Cerkvenik, Jeff, Daubert, Claude

“…The benefit of cardiac resynchronization therapy (CRT) among patients with mild heart failure (HF), reduced left ventricular (LV) function and wide QRS is well…”
Get full text

Head-To-Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study by GOLD, MICHAEL R., THEUNS, DOMINIC A., KNIGHT, BRADLEY P., STURDIVANT, J. LACY, SANGHERA, RICK, ELLENBOGEN, KENNETH A., WOOD, MARK A., BURKE, MARTIN C.

“…Arrhythmia Detection with S‐ICD Versus Transvenous ICDs. Background: The development of a totally subcutaneous implantable defibrillator (S‐ICD) system…”
Get full text

Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results by Gold, Michael R., Aasbo, Johan D., El-Chami, Mikhael F., Niebauer, Mark, Herre, John, Prutkin, Jordan M., Knight, Bradley P., Kutalek, Steven, Hsu, Kevin, Weiss, Raul, Bass, Eric, Husby, Michael, Stivland, Timothy M., Burke, Martin C.

“…The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to reduce short- and long-term complications associated with transvenous ICD…”
Get full text

Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts by Lambiase, Pier D., PhD, FHRS, FRCP, Gold, Michael R., MD, PhD, Hood, Margaret, MB, Boersma, Lucas, MD, PhD, Theuns, Dominic A.M.J., PhD, Burke, Martin C., DO, Weiss, Raul, MD, Russo, Andrea M., MD, Kääb, Stefan, MD, PhD, Knight, Bradley P., MD

“…Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is a potential alternative to transvenous systems in hypertrophic cardiomyopathy…”
Get full text

Beta Blocker Therapy for Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia: Are all beta blockers equivalent? by Ackerman, Michael J., MD, PhD, Priori, Silvia G., MD, PhD, Dubin, Anne, MD, FHRS, Kowey, Peter, MD, Linker, Nicholas J., MD, FHRS, Slotwiner, David, MD, FHRS, Triedman, John, MD, FHRS, CCDS, CEPS, Van Hare, George F., MD, FHRS, CCDS, CEPS, Gold, Michael R., MD, PhD, FHRS

Get full text